Market Overview

UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on Mead Johnson Nutrition

Share:
Related MJN
Mead Johnson Dips Lower On Competitive Concerns In China
Goldman Shuffles Consumer Focus List: Cuts Mead Johnson, Adds Dollar Tree And TJX Cos.
Mead Johnson Nutrition (MJN) Peter Kasper Jakobsen on Q1 2016 Results - Earnings Call Transcript (Seeking Alpha)

In a report published Friday, Deutsche Bank reiterated its Buy rating on Mead Johnson Nutrition (NYSE: MJN), and raised its price target from $77.00 to $81.00.

Deutsche Bank noted, “Affirm BUY Opinion - In the face of building pessimism in late 2012 and into 2013, we maintained an optimistic view on Mead. With broad share gains in a typically rational and highly profitable category, the LT outlook remains bright. With an eventual U.S. recovery, non-China EM markets ramping up and good prospects in China/HK along with a reasonable global CPG valuation, we retain our BUY.”

Mead Johnson Nutrition closed on Thursday at $76.00.

Latest Ratings for MJN

DateFirmActionFromTo
Apr 2016CitigroupMaintainsBuy
Mar 2016Credit SuisseUpgradesNeutralOutperform
Jan 2016Credit SuisseMaintainsNeutral

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Price Target Analyst Ratings

 

Related Articles (MJN)

View Comments and Join the Discussion!